AMSTERDAM, January 12, 2012 /PRNewswire/ --

Acquisition enhances Elsevier's ability to help researchers and information professionals improve their search, retrieval and content management efficiency

Elsevier, the world-leading provider of scientific, technical, and medical information products and services, announced today the acquisition of QUOSA a content management and workflow productivity solutions provider for researchers and information managers.

QUOSA's current solutions and platform, including its Information Manager and Virtual Library, will continue to be supported. QUOSA's technological capabilities will be developed into Elsevier-branded solutions, raising the efficiency of the search and discovery process. They will also allow researchers and information professionals to manage information more efficiently at the various stages of the research workflow including organizing, archiving and sharing.  

"Elsevier is focused on delivering productivity enhancing tools to researchers and information managers to help accelerate and promote scientific discovery. Our acquisition of QUOSA ensures that we continue to deliver more value to our customers by improving the search, retrieval, management, analysis and sharing of the increasingly disparate types of information required to improve research outcomes," said Alexander van Boetzelaer, Managing Director of Elsevier Corporate Markets. "QUOSA brings to Elsevier an innovative offering and technological expertise that align well with Elsevier today."

Elsevier and QUOSA have collaborated successfully since 2007 when the latter's PDF Download Manager was incorporated in SciVerse Scopus.  Later the feature was embedded in SciVerse ScienceDirect. Elsevier's acquisition of QUOSA marks a continuation of this collaboration which has boosted research productivity for the users of both solutions.  

"QUOSA empowers enterprises to share full-text scientific information faster and more efficiently, helping users to get more out of their information while controlling costs, all with one easy-to-use copyright observant solution," said Malcolm MacKenzie, President and CEO, QUOSA. "Both our customers and the wider research community stand to benefit from the pooling of resources and expertise with Elsevier."  

Founded in 1996 and headquartered in Boston, QUOSA began by targeting the academic and government segments and now also serves a range of corporate customers, including more than half of the Top 25 pharma-biotech companies. Financial details of the acquisition are not being disclosed.  

About QUOSA - The ONE Scientific Literature Solution

QUOSA Inc. is a specialist software company focused on literature management workflows and archives, which include full-text articles and patents. With a large and rapidly growing subscriber-base at leading universities, pharmaceutical, biotechnology and other life-science companies, and in other research and medical centers, QUOSA's applications are used to compress the time to insight and action across the key functions of the innovation enterprise. For more information about QUOSA, please visit the website at http://www.quosa.com.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Reller
Vice President, Global Corporate Relations, Elsevier
+1-215-239-3508
t.reller@elsevier.com

SOURCE Elsevier